INCY News and Press, Incyte Corporation From 01/25/22

Incyte (Nasdaq:INCY) today announced updates regarding the clinical development of parsaclisib, the Company’s next-generation oral inhibitor of phosphatidylinositol 3-kinase delta (PI3Kδ), and MCLA-145, its CD137/PD-L1 bispecific antibody co-developed under a global collab...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific...

Even the best investors don't always beat the market over relatively short periods, say 12 months, for instance. Case in point: Last year Cathie Wood, CEO of the asset management company ARK Invest, was one big name in the investing world whose actively managed, exchange-traded funds (ETFs)...

With COVID-19 mutating into newer, more transmissible variants, biotechnology stocks have the potential to again outperform as authorities worldwide redouble their efforts at mass vaccinations. So, we think it could be wise to now add quality biotech stocks Vertex Pharmaceuticals (VRTX), BioN...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 20, 2021 – USA News Group –  As the 2021 San Antonio Breast Cancer Symposium (SABCS) comes to a close, many of this year’s presenters provided very encourag...

Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2021 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 8, 2022. The schedule for the press release and conference call/webcast is as follows: If you are u...

FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 14, 2022 – USA News Group –  Cancer cases are on the rise, according to a new study comparing the number of cancer diagnoses globally in 2010 and 2019. Among the ...

VANCOUVER – USA News Group – Cancer cases are on the rise, according to a new study comparing the number of cancer diagnoses globally in 2010 and 2019. Among the data, researchers witnessed that global cancer rates were up by +26% and that breast cancer was the leading...

With the COVID-19 omicron variant wreaking havoc globally, the healthcare industry is again attracting significant attention. Therefore, we think it could be wise to bet on quality healthcare stocks Medtronic (MDT), Zimmer Biomet (ZBH), and Incyte (INCY) now. Read on. The omicron variant...

In his book “Super Stocks” published nearly 40 years ago, Ken Fisher described an investing philosophy about high growth companies, trading at a discount. The philosophy combines elements of high growth and value, including both quantitative and qualitative factors. ...